Millia C, Nicoletti F, Grasso AA, Patti F, Condorelli DF, Rapisarda E, Rampello L, Costa G, Scapagnini U. Effects of dopaminergic drugs on cerebellar prostaglandin concentrations.
J Neurochem 1983;
41:1190-1. [PMID:
6578301 DOI:
10.1111/j.1471-4159.1983.tb09072.x]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Previous data indicate that the injection of dopaminergic drugs induces changes in cerebellar 3',5'-guanosine monophosphate (cGMP) content. Accordingly, we have investigated the effects of haloperidol, sulpiride, or apomorphine on cerebellar prostaglandin (PG) concentration, a parameter related to cGMP content. Results obtained show that dopamine receptor blocking agents, such as haloperidol and sulpiride, significantly decrease cerebellar PGE2 and PGF2 alpha concentrations, while opposite changes are induced by apomorphine, a dopamine receptor agonist.
Collapse